期刊文献+

血管内皮生长因子全长抗体在毕赤酵母中的表达与活性鉴定 被引量:2

Expression of VEGF Full Length Antibody in Pichia pastoris and its Activity Detection
下载PDF
导出
摘要 目的:构建血管内皮生长因子(VEGF)全长抗体表达载体pPICZαA-VH-CH-VL-CL,评价其在毕赤酵母中的表达产物与抗原的结合特性,及其抑制细胞增殖的活性。方法:利用基因合成分别获得VEGF抗体CL和CH序列,分别构建pPICZαA-CH和pPICZαA-CL重组质粒,再利用同尾酶特性构建双启动子表达盒的重组pPICZαA-CH-CL载体,用Westen印迹对其进行表达鉴定后将VH和VL序列插入该载体,获得VEGF的全长抗体表达载体pPICZαA-VH-CH-VL-CL;通过膜筛和ELISA进行菌株筛选,并对VEGF抗体表达阳性菌株进行小量表达和纯化,采用CCK-8法对其抑制人脐静脉内皮细胞(HUVEC)增殖的活性进行初步评价。结果:获得表达轻、重链的VEGF抗体表达载体,ELISA实验证明pPICZαA-VH-CH-VL-CL具有一定的VEGF抗原结合特性;体外增殖实验表明,该抗体可以以剂量依赖性抑制HUVEC增殖。结论:在毕赤酵母中表达、纯化了具有一定功能活性的VEGF全长抗体,为后续比较研究酵母糖基化改造对VEGF抗体的药效学和药代学的影响提供了基础。 Objective: To construct and express the full-length human vascular endothelial growth factor(VEGF) antibody in Phchia pastoris yeast and evaluate the antibody characteristic and ability to inhibit human umbilical vein endothelial cells(HUVEC) growth. Methods: VEGF constant region genes of the heavy and light chains(CH and CL) antibody sequences were synthesized and were cloned to pPICZαA, respectively, to make pPICZαA-CH and pPICZαA-CL. Then we constructed the double promoter series expression vector pPICZαA-CH-CL using iso-caudarner BglⅡ and BamHⅠ. The expressed product were identified by Western blot and full-length human VEGF antibody-expressed vector, pPICZαA-VH-CH-VL-CL, were constructed by inserting the VEGF varient re-gion genes of the CL and CH into pPICZαA-CH-CL. Blotting and ELISA were performed to screened the optimal clone. After purification by Nickel affinity purification column, the purified proteins were used to evaluate the HU-VEC growth by CCK-8 assay. Results: The full-length human VEGF antibody pPICZαA-VH-CH-VL-CL was suc-cessfully constructed and expressed by sequencing and Western blot. ELISA showed that the VEGF antibody has affinity with the VEGF antigen. In addition, the purified VEGF antibody could inhibit cell growth in dose manner. Conclusion: We successfully constructed and expressed the functional full-length human VEGF antibody in P.pas-toris yeast, which lay establishment to the comparison study of VEGF antibody pharmacokinetics and pharmacody-namics in wild and N-glycoengineered P.pastoris.
出处 《生物技术通讯》 CAS 2014年第4期492-496,共5页 Letters in Biotechnology
基金 国家自然科学基金(81272701/H1617) 北京市自然科学基金(5113034)
关键词 血管内皮生长因子 毕赤酵母 抗体 肿瘤增殖 vascular endothelial growth factor Phchia pastoris human full-length antibody tumor inhibition
  • 相关文献

参考文献10

  • 1Helenius A, Aebi M. Intracellular functions of N-linked gly- cans[J]. Science, 2001,291(5512):2364-2369. 被引量:1
  • 2Mitra N, Sinha S, Ramya T N, et al. N-linked oligosaccha- rides as outfitters for glycoprotein folding, and function[J]. Trends Biochem Sci, 2006,31(3):156-163. 被引量:1
  • 3王越,巩新,唱韶红,刘波,宋淼,黄海华,吴军.α-1,6-甘露糖转移酶基因敲除的毕赤酵母菌株构建及其用于融合蛋白HSA/GM-CSF表达的研究[J].生物工程学报,2007,23(5):907-914. 被引量:17
  • 4高新,宋海峰.构建表达预定糖链修饰糖蛋白工程菌株的方法[P].中国,200810007439,2009-01-14. 被引量:2
  • 5Rothman R J, Perussia B, Herlyn D, et al. Antibody-depen- dent cytotoxicity mediated by natural killer cells is enhanced by castanospermine-induced alterations of IgG glycosylation[J]. Mol Immunol, 1989,26(12):1113-1123. 被引量:1
  • 6Cohen-Solal J F, Cassard L, Fridman W H, et al. Fc gamma receptors[J]. Immunol Lett, 2004,92(3):199-205. 被引量:1
  • 7Junghans R P. Finally! The Brambell receptor(FcRB). Media- tor of transmission of immunity and protection from catabo- lism for IgG[J]. Immunol Res, 1997,16(1):29-57. 被引量:1
  • 8Hamilton S R, Davidson R C, Sethuraman N, et al. Humaniza- tion of yeast to produce complex terminally sialyated glycopro- teins[J]. Science, 2006,313(5792):1441-1443. 被引量:1
  • 9Li H, Sethuraman N, Stadheim T A, et al. Optimization of hu- manized IgGs in glycoengineered Piehia pastoris[J]. Nat Bio- technol, 2006,24(2):210-215. 被引量:1
  • 10Potgieter T I, Cukan M, Drummond J E, et al. Production of monoclonal antibodies by glycoengineered Pichia pastoris[J]. J Biotechnol, 2009,139(4):318-325. 被引量:1

二级参考文献18

  • 1唱韶红,巩新,杨志愉,王同映,马国昌,马清钧,吴军.人血清白蛋白和人干扰素α2b的融合蛋白在毕赤酵母中的表达[J].生物工程学报,2006,22(2):173-179. 被引量:16
  • 2Helenius A,Aebi M.Intracellular funcation of N-linked glycans.Science,2001,291(5512):2364-2369. 被引量:1
  • 3Cregg JM,Cereghino JI,Shi J,et al.Recombinant protien expression in Pichia pastoris.Mol Biotechnol,2000,16(1):23 -52. 被引量:1
  • 4Hubbard SC,Ivatt RJ.Synthesis and processing of asparaginelinked oligosaccharides.Anna Rev Biochem,1981,50(7):555 -583. 被引量:1
  • 5Walsh G.Biopharmaceutical benchmarks-2003.Nature Biotechnol,2003,21(8):865-870. 被引量:1
  • 6Wildt S,Gerngross TU.The humanization of N-glycosylation pathways in yeast.Nature Microbiology,2005,3(2):119-128. 被引量:1
  • 7Li H,Sethuraman N,Stadheim TA,et al.Optimization of humanized IgGs in glycoengineered Pichia pastoris.Nature biotechnology,2006,24(2):210-215. 被引量:1
  • 8Hamiltone SR,Davidson R,Sethuraman N,et al.Humanization of yeast to produce complex terminally sialylated glycoproteins.Science,2006,313(8):1441-1443. 被引量:1
  • 9Bobrowicz P,Davidson RC,Li H,et al.Engineering of an artificial glycosylation pathway blocked in core oligosaccharide assembly in the yeast Pichia pastoris:production of complex humanized glycopreteins with terminal galactose.Glycobiology,2004,14(9):757-766. 被引量:1
  • 10Batova A,Kamps A,Gillies SD,et al.The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro.Clin Cancer Res,1999,5(12):4259-4263. 被引量:1

共引文献17

同被引文献4

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部